BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 18344888)

  • 1. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy in the secondary prophylaxis of variceal rebleeding in cirrhotic patients: meta-analysis update.
    Zheng M; Chen Y; Bai J; Zeng Q; You J; Jin R; Zhou X; Shen H; Zheng Y; Du Z
    J Clin Gastroenterol; 2008; 42(5):507-16. PubMed ID: 18344888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis.
    Papatheodoridis GV; Goulis J; Leandro G; Patch D; Burroughs AK
    Hepatology; 1999 Sep; 30(3):612-22. PubMed ID: 10462365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding.
    Lo GH; Liang HL; Chen WC; Chen MH; Lai KH; Hsu PI; Lin CK; Chan HH; Pan HB
    Endoscopy; 2007 Aug; 39(8):679-85. PubMed ID: 17661241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost analysis for the prevention of variceal rebleeding: a comparison between transjugular intrahepatic portosystemic shunt and endoscopic sclerotherapy in a selected group of Italian cirrhotic patients.
    Meddi P; Merli M; Lionetti R; De Santis A; Valeriano V; Masini A; Rossi P; Salvatori F; Salerno F; de Franchis R; Capocaccia L; Riggio O
    Hepatology; 1999 Apr; 29(4):1074-7. PubMed ID: 10094949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic therapy for the prevention of recurrent esophageal variceal bleeding.
    Russo MW; Zacks SL; Sandler RS; Brown RS
    Hepatology; 2000 Feb; 31(2):358-63. PubMed ID: 10655258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T.).
    Merli M; Salerno F; Riggio O; de Franchis R; Fiaccadori F; Meddi P; Primignani M; Pedretti G; Maggi A; Capocaccia L; Lovaria A; Ugolotti U; Salvatori F; Bezzi M; Rossi P
    Hepatology; 1998 Jan; 27(1):48-53. PubMed ID: 9425916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial.
    Henderson JM; Boyer TD; Kutner MH; Galloway JR; Rikkers LF; Jeffers LJ; Abu-Elmagd K; Connor J;
    Gastroenterology; 2006 May; 130(6):1643-51. PubMed ID: 16697728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early TIPS versus endoscopic therapy for secondary prophylaxis after management of acute esophageal variceal bleeding in cirrhotic patients: a meta-analysis of randomized controlled trials.
    Halabi SA; Sawas T; Sadat B; Jandali A; Halabi HA; Halabi FA; Kapoor B; Carey WD
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1519-26. PubMed ID: 26858143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone versus TIPS combined with embolotherapy in advanced cirrhosis: a retrospective study.
    Xiao T; Chen L; Chen W; Xu B; Long Q; Li R; Li L; Peng Z; Fang D; Wang R
    J Clin Gastroenterol; 2011 Aug; 45(7):643-50. PubMed ID: 21301360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic role of the initial portal pressure gradient reduction after TIPS in patients with cirrhosis.
    Biecker E; Roth F; Heller J; Schild HH; Sauerbruch T; Schepke M
    Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):846-52. PubMed ID: 17873607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIPS versus endoscopic therapy for variceal rebleeding in cirrhosis: A meta-analysis update.
    Zhang H; Zhang H; Li H; Zhang H; Zheng D; Sun CM; Wu J
    J Huazhong Univ Sci Technolog Med Sci; 2017 Aug; 37(4):475-485. PubMed ID: 28786052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic variceal ligation plus propranolol vs. transjugular intrahepatic portosystemic stent shunt: a long-term randomized trial.
    Sauer P; Hansmann J; Richter GM; Stremmel W; Stiehl A
    Endoscopy; 2002 Sep; 34(9):690-7. PubMed ID: 12195325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic efficacy of transjugular intrahepatic portosystemic shunt on bleeding gastric varices].
    Song HG; Lee HC; Park YH; Jung S; Chung YH; Lee YS; Yoon HK; Sung KB; Suh DJ
    Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):448-57. PubMed ID: 12506249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urgent transjugular intrahepatic portosystemic shunt for control of acute variceal bleeding.
    Bañares R; Casado M; Rodríguez-Láiz JM; Camúñez F; Matilla A; Echenagusía A; Simó G; Piqueras B; Clemente G; Cos E
    Am J Gastroenterol; 1998 Jan; 93(1):75-9. PubMed ID: 9448179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.
    Brand M; Prodehl L; Ede CJ
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001023. PubMed ID: 30378107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of transjugular intrahepatic portosystemic shunt in the management of bleeding ectopic varices in cirrhotic patients.
    Vidal V; Joly L; Perreault P; Bouchard L; Lafortune M; Pomier-Layrargues G
    Cardiovasc Intervent Radiol; 2006; 29(2):216-9. PubMed ID: 16284702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage.
    García-Villarreal L; Martínez-Lagares F; Sierra A; Guevara C; Marrero JM; Jiménez E; Monescillo A; Hernández-Cabrero T; Alonso JM; Fuentes R
    Hepatology; 1999 Jan; 29(1):27-32. PubMed ID: 9862845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of variceal rebleeding in cirrhotic patients with spontaneous portosystemic shunts: transjugular intrahepatic portosystemic shunt versus endoscopic treatment.
    Zhang H; Xiao J; Tu J; Zhang M; Zhang F; Yin Q; Zhuge Y
    Eur J Gastroenterol Hepatol; 2021 May; 33(5):752-761. PubMed ID: 33731589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding.
    Mahadeva S; Bellamy MC; Kessel D; Davies MH; Millson CE
    Am J Gastroenterol; 2003 Dec; 98(12):2688-93. PubMed ID: 14687818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.